Kyverna Therapeutics, Inc.
KYTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127 | -$60 | -$29 | -$26 |
| Dep. & Amort. | $2 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $2 | $1 | $7 |
| Change in WC | $8 | $3 | -$10 | -$4 |
| Other Non-Cash | -$5 | $1 | $1 | $1 |
| Operating Cash Flow | -$114 | -$52 | -$36 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$490 | -$55 | -$56 | $0 |
| Inv. Sales/Matur. | $324 | $47 | $43 | $0 |
| Other Inv. Act. | $8 | $0 | $0 | $0 |
| Investing Cash Flow | -$161 | -$9 | -$14 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$0 | -$0 |
| Stock Issued | $341 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $59 | $12 | $73 |
| Financing Cash Flow | $337 | $58 | $12 | $73 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $62 | -$3 | -$38 | $49 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $38 | $77 | $28 |
| End Cash | $97 | $35 | $38 | $77 |
| Free Cash Flow | -$116 | -$53 | -$37 | -$23 |